Introduction
Table of Contents
Common invasive fungal pathogens that frequently affect cancer patients, especially those who are immunocompromised due to chemotherapy, hematologic malignancies, or bone marrow/stem cell transplants.
List of Common Invasive Fungal Pathogens
1. Candida species
- Candida albicans (most common)
- Candida glabrata
- Candida tropicalis
- Candida parapsilosis
- Candida krusei
Causes: Candidemia, disseminated candidiasis
Risk: Neutropenia, central venous catheter, broad-spectrum antibiotics
2. Aspergillus species
- Aspergillus fumigatus (most frequent)
- Aspergillus flavus
- Aspergillus niger
- Aspergillus terreus
- Aspergillus lentulus
Causes: Invasive pulmonary aspergillosis (IPA), sinusitis, disseminated infection
Risk: Prolonged neutropenia, corticosteroids, hematologic malignancy
3. Mucorales (Zygomycetes)
- Rhizopus, Mucor, Lichtheimia, Rhizomucor species
Causes: Rhinocerebral, pulmonary, or disseminated mucormycosis
Risk: Hematologic malignancy, diabetes, iron overload, voriconazole use
4. Fusarium species
Causes: Skin lesions, fungemia, pneumonia
Risk: Profound neutropenia, acute leukemia, HSCT
5. Scedosporium species
- Scedosporium apiospermum, Lomentospora prolificans
Causes: Pulmonary, brain abscess, disseminated infections
Risk: Immunosuppression, organ transplant
6. Cryptococcus neoformans / gattii
Causes: Meningitis, pulmonary or disseminated cryptococcosis
Risk: AIDS, corticosteroid therapy, hematologic malignancy
7. Pneumocystis jirovecii
Causes: Pneumocystis pneumonia (PCP)
Risk: T-cell dysfunction, high-dose steroids, lymphoma, transplant patients
8. Talaromyces marneffei (in endemic areas like Southeast Asia)
Causes: Disseminated talaromycosis
Risk: HIV/AIDS, solid organ or hematologic malignancies
Risk Factors of Common Invasive Fungal Pathogens in Cancer Patients
Key Risk Factors in Cancer Patients:
- Neutropenia (ANC <500/mm³)
- Prolonged corticosteroid therapy
- HSCT or solid organ transplant
- Broad-spectrum antibiotics
- Mucosal damage (e.g., mucositis)
Keynotes
- Cancer patients are at high risk due to immunosuppression, mucosal injury, and indwelling devices.
- Timely diagnosis is crucial; delayed treatment worsens outcomes.
- Empiric antifungal therapy is often started in febrile neutropenic patients.
- Species identification and susceptibility testing are crucial due to the emergence of resistance patterns.
1. Candida species
- The most common cause of fungemia in cancer patients.
- Species include: Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei.
- Risk factors: Neutropenia, central venous catheters, broad-spectrum antibiotics, mucositis.
- Clinical forms: Candidemia, hepatosplenic candidiasis, endophthalmitis.
- Resistance: C. glabrata shows reduced azole susceptibility.
2. Aspergillus species
- Aspergillus fumigatus is the leading mold in immunocompromised hosts.
- Causes: Invasive pulmonary aspergillosis (IPA), sinusitis, cerebral aspergillosis.
- Risk factors: Prolonged neutropenia, HSCT, steroids.
- Diagnosis: Galactomannan assay, CT scan (halo sign), fungal culture, PCR.
- Voriconazole is the first-line treatment; A. terreus is resistant to amphotericin B.
3. Cryptococcus neoformans / gattii
- Causes meningoencephalitis, especially in AIDS and cancer patients.
- Encapsulated yeast, as seen in the India ink or CrAg test, is positive.
- Inhalation route: disseminates to the CNS.
- Risk: T-cell suppression, hematologic malignancy.
- Treatment: Amphotericin B + flucytosine, followed by fluconazole.
4. Mucorales (Mucormycosis)
- Agents: Rhizopus, Mucor, Lichtheimia.
- Rapidly progressive and angioinvasive mold.
- Forms: Rhinocerebral, pulmonary, GI, disseminated.
- Risk: Uncontrolled diabetes, iron overload, and voriconazole prophylaxis.
- Amphotericin B is the treatment of choice; surgical debridement is often required.
5. Fusarium species
- Common in profound neutropenia and leukemia.
- Causes: Skin lesions, disseminated fungemia, pneumonia.
- Blood cultures are often positive, unlike aspergillosis.
- High resistance to antifungals; voriconazole/liposomal amphotericin B used.
6. Scedosporium / Lomentospora
- Found in soil; causes infection in immunocompromised patients.
- May mimic Aspergillus but is resistant to amphotericin B.
- Often disseminated; CNS involvement is common.
- Voriconazole is the drug of choice.
7. Pneumocystis jirovecii
- Causes atypical interstitial pneumonia (PCP) in T-cell deficiency (e.g., lymphoma).
- Symptoms: Dry cough, fever, hypoxia, diffuse infiltrates on X-ray.
- Diagnosis: Giemsa/Grocott stain, PCR, β-D-glucan positive.
- Treatment: TMP-SMX; prophylaxis in high-risk patients.
8. Talaromyces marneffei
- Dimorphic fungus, endemic in Southeast Asia, including Nepal.
- Disseminated infection in AIDS or hematologic malignancies.
- Shows red pigment on SDA at 25°C; yeast cells with central septa in tissues.
- Treated with amphotericin B followed by itraconazole.
Further Readings
- https://www.dgho.de/arbeitskreise/a-g/agiho/leitlinien/mykosen-antimykotika-therapie-ifd-agiho-ruhnke-rev-mycoses2020-1.pdf
- https://onlinelibrary.wiley.com/doi/10.1111/myc.13082
- https://www.sciencedirect.com/science/article/pii/S0924857912000064
- https://www.cochrane.org/CD000026/GYNAECA_prevention-fungal-infections-patients-cancer-antifungal-drugs
- https://www.dovepress.com/invasive-candidiasis-in-patients-with-solid-tumors-a-single-center-ret-peer-reviewed-fulltext-article-IJGM
- https://www.cancernetwork.com/view/management-fungal-and-viral-infections-cancer-patients
- https://www.artemishospitals.com/blog/black-fungus-mucormycosis-types-causes-symptoms-treatment
- https://www.dgho.de/arbeitskreise/a-g/agiho/leitlinien/mykosen-antimykotika-therapie-ifd-agiho-ruhnke-rev-mycoses2020-1.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7916227/
- https://www.ncbi.nlm.nih.gov/books/NBK13518/
- https://www.producer.com/livestock/this-weird-algae-can-cause-severe-infections-in-animals/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4047064/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6711263/